KRAS and adenocarcinoma: In particular, 45 adenocarcinomas (41 colon, 2 lung, 2 pancreas) exhibited co-occurring KRAS and PIK3CA mutations; two colon adenocarcinomas had concomitant BRAF and PIK3CA mutations.